Font: Financial Modeling Prep • Apr 27, 2026
Business First Bancshares (NASDAQ:BFST) is the parent company of b1BANK. It operates as a community bank providing a range of financial services. A notable recent event for the company was the completion of its acquisition of Progressive Bancorp, Inc. BFST currently has a market capitalization of approximately $883.02 million.
On April 27, 2026, an analyst from Stephens lowered the price target for BFST to $33.00 from $34.00. When this target was set, the stock price was $27.01. This new price target suggests a potential upside of about 22.18% from its price at the time of the announcement.
The company's financial results provide context for this analysis. For the first quarter of 2026, BFST reported earnings per share (EPS) of $0.73. This figure, which shows the profit per share, was a 5.8% positive surprise over the Zacks Consensus Estimate of $0.69. It also marks an increase from the $0.65 EPS reported a year ago.
On the revenue side, the company generated $89.25 million for the quarter ending in March 2026. This represents a 12.7% increase from the prior year's quarter. However, this revenue figure was a slight miss of 0.65% compared to the consensus estimate of $89.83 million, as highlighted by Zacks.
As reported by GlobeNewswire, the company's net income for the first quarter was $22.20 million. On the day of these announcements, BFST's stock price experienced a 4.42% drop, closing at $27.01. Over the past 52 weeks, the stock has traded between a low of $22.52 and a high of $30.32.
|
CHSN§>
Chanson International Holding
|
$0.05
-70.71%
|
|
CTNT§>
Cheetah Net Supply Chain Service Inc.
|
$0.03
-34.12%
|
|
ASBP§>
Aspire Biopharma Holdings, Inc.
|
$0.25
19.51%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$14.03
3.77%
|
|
POET§>
POET Technologies Inc.
|
$7.95
-47.35%
|
|
USEG§>
U.S. Energy Corp.
|
$1.06
14.34%
|
|
NVDA§>
NVIDIA Corporation
|
$216.61
4.00%
|
|
INTC§>
Intel Corporation
|
$84.99
2.97%
|
|
YAAS§>
Youxin Technology Ltd
|
$2.32
149.62%
|
|
CMPX§>
Compass Therapeutics, Inc.
|
$1.79
-64.38%
|